The Survivors Taking Action and Responsibility (STAR) Program provides risk-based care using national and international survivorship guidelines for childhood cancer and hematopoietic stem cell transplant survivors. Our program also participates in research to contribute to ongoing improvements in survivorship care and the quality of life of survivors.
Over 85% of children diagnosed with cancer can expect to be cured, due to innovations in chemotherapy, radiation therapy, surgery and stem cell transplant, as well as increased understanding of the biology of cancer. Pediatric cancer treatments can create persisting side effects, becoming what are known as “late effects.” The STAR Program addresses late effects of pediatric cancer and hematopoietic stem cell transplant treatment in children and young adults.
Patients are referred to the STAR program five years after a cancer diagnosis if they are in full clinical remission, or two years following hematopoietic stem cell transplant. Patients are seen annually. We currently see over 550 patients each year.